Organizational oscillation between learning and forgetting: The dual role of serious errors

Organization Science

Volumn 26, Issue 6, 2015, Pages 1682-1701

  Haunschild, Pamela R ^a   Polidoro, Francisco ^a   Chandler, David ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Errors; Innovation; Organizational forgetting; Organizational learning; Organizational oscillation; Safety

Indexed keywords

EID: 84950988097     PISSN: 10477039     EISSN: 15265455     Source Type: Journal    
DOI: 10.1287/orsc.2015.1010     Document Type: Article

References (102)

1. Abernathy WJ, Utterback JM (1978) Patterns of industrial innovation. Tech. Rev. 80(7):40-47.
2. Adler PS, Goldoftas B, Levine DI (1999) Flexibility versus efficiency? A case study of model changeovers in the Toyota production system. Organ. Sci. 10(1):43-68.
3. Amgen (2005) Fighting serious illness: Amgen 2005 annual report. Report, Amgen, Thousand Oaks, CA.
4. Amgen (2006) Our promise: Amgen 2006 annual report. Report, Amgen, Thousand Oaks, CA.
5. Anderson JM (2008) Understanding mass tort defendant incentives for confidential settlements: Lessons from Bayer's cerivastatin litigation strategy. Working Paper WR-617-ICJ, RAND Institute for Civil Justice, Santa Monica, CA.
6. Argote L (2011) Organizational learning research: Past, present and future. Management Learn. 42(4):439-446.
7. Argote L (2013) Organizational Learning: Creating, Retaining and Transferring Knowledge, 2nd ed. (Springer, New York).
8. Argote L, Miron-Spektor E (2011) Organizational learning: From experience to knowledge. Organ. Sci. 22(5):1123-1137.
9. Argote L, Beckman SL, Epple D (1990) The persistence and transfer of learning in industrial settings. Management Sci. 36(2): 140-154.
10. Argote L, McEvily B, Reagans R (2003) Managing knowledge in organizations: An integrative framework and review of emerging themes. Management Sci. 49(4):571-582.
11. Barley SR, Kunda G (1992) Design and devotion: Surges of rational and normative ideologies of control in managerial discourse. Admin. Sci. Quart. 37(3):363-399.
12. Baum JAC, Dahlin KB (2007) Aspiration performance and railroads' patterns of learning from train wrecks and crashes. Organ. Sci. 18(3):368-385.
13. Baumard P, Starbuck WH (2005) Learning from failures: Why it may not happen. Long Range Planning 38(3):281-298.
14. Beck TE, Plowman DA (2014) Temporary, emergent interorganizational collaboration in unexpected circumstances: A study of the Columbia space shuttle response effort. Organ. Sci. 25(4): 1234-1252.
15. Beckman CM, Haunschild PR (2002) Network learning: The effects of partners' heterogeneity of experience on corporate acquisitions. Admin. Sci. Quart. 47(1):92-124.
16. Berenson A (2007) Merck agrees to settle Vioxx suits for $4.85 billion. New York Times (November 9), http://www.nytimes.com/2007/11/09/business/09merck.html?_r=0.
17. Berger AN, Udell GF (2004) The institutional memory hypothesis and the procyclicality of bank lending behavior. J. Financial Intermediation 13(4):458-495.
18. Birkinshaw J, Gupta K (2013) Clarifying the distinctive contribution of ambidexterity to the field of organization studies. Acad. Management Perspect. 27(4):287-298.
19. Bohmer RMJ, Edmondson A, Roberto M Feldman L, Ferlins E (2004) Columbia's final mission. HBS Case 9-304-090, Harvard Business School, Boston.
20. Bosch J-C, Lee I (1994) Wealth effects of Food and Drug Administration (FDA) decisions. Managerial Decision Econom. 15(6): 589-599.
21. Boston Business Journal (2003) Sepracor drops Soltara drug. (December 2), http://www.bizjournals.com/boston/stories/2003/12/01/daily17.html.
22. CAIB (Columbia Accident Investigation Board) (2003) Columbia Accident Investigation Board report, Vol. 1. Report, Columbia Accident Investigation Board, Arlington, VA.
23. Carroll JS (1995) Incident reviews in high-hazard industries: Sense making and learning under ambiguity and accountability. Organ. Environment. 9(2):175-197.
24. Caves RE, Whinston MD, Hurwitz MA, Pakes A, Temin P (1991) Patent expiration, entry, and competition in the U.S. pharmaceutical industry. Brookings Papers Econom. Activity Microeconomics, 1-66.
25. Center for Drug Evaluation and Research (2005) CDER 2005 report to the nation: Improving public health through human drugs. Report, U.S. Food and Drug Administration, Rockville, MD.
26. Chandler D (2014) Organizational susceptibility to institutional complexity: Critical events driving the adoption and implementation of the ethics and compliance officer position. Organ. Sci. 25(6):1722-1743.
27. Chandler D (2015) Why institutions matter: Stakeholder attention to organizational ethics commitments. Kraatz MS, ed. Institutions and Ideals: Philip Selznick's Legacy for Organizational Studies, Research in the Sociology of Organizations, Vol. 44 (Emerald Group Publishing, Bingley, UK), 199-233.
28. Chandler D, Hwang H (2015) Learning from learning theory: A model of organizational adoption strategies at the microfoundations of institutional theory. J. Management. 41(5):1446-1476.
29. Cockburn IM, Henderson R, Stern S (2000) Untangling the origins of competitive advantage. Strategic Management J. 21(10-11): 1123-1145.
30. Cohen WM, Nelson RR, Walsh JP (2000) Protecting their intellectual assets: Appropriability conditions and why U.S. manufacturing firms patent (or not). NBER Working Paper 7552, National Bureau of Economic Research, Cambridge, MA.
31. Cyert RM, March JG (1963) A Behavioral Theory of the Firm (Prentice-Hall, Englewood Cliffs, NJ).
32. Danzon PM (2000) The pharmaceutical industry. Bouckaert B, De Geest G, eds. The Encyclopedia of Law and Economics (Edward Elgar, Cheltenham, UK), 1055-1091.
33. Day GS (1994) The capabilities of market-driven organizations. J. Marketing 58(4):37-52.
34. Denrell J (2003) Vicarious learning, undersampling of failure, and the myths of management. Organ. Sci. 14(3):227-243.
35. DeRuiter J, Holston PL (2012) Drug patent expirations and the "patent cliff." U.S. Pharmacist 37(6):12-20.
36. Dillon RL, Tinsley CH (2008) How near-misses influence decision making under risk: A missed opportunity for learning. Management Sci. 54(8):1425-1440.
37. DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: New estimates of drug development costs. J. Health Econom. 22(2):151-185.
38. Eisenhardt KM (1989) Building theories from case study research. Acad. Management Rev. 14(4):532-550.
39. Eisenhardt KM, Graebner ME (2007) Theory building from cases: Opportunities and challenges. Acad. Management J. 50(1): 25-32.
40. Farjoun M (2005) Organizational learning and action in the midst of safety drift: Revisiting the space shuttle program's recent history. Starbuck WH, Farjoun M, eds. Organization at the Limit: Lessons from the Columbia Disaster (Wiley-Blackwell, Oxford, UK), 60-80.
41. Flapan D (2004) Vioxx pulled from global market. Medscape Medical News (September 30), http://www.medscape.com/viewarticle/490355.
42. Furberg C, Pitt B (2001) Withdrawal of cerivastatin from the world market. Current Controlled Trials Cardiovascular Medicine 2(5): 205-207.
43. Gilbert D, Scheck J (2014) BP is found grossly negligent in Deepwater Horizon disaster. Wall Street Journal (September 4), http://www.wsj.com/articles/u-s-judge-finds-bp-grossly-negligent-in-2010-deepwater-horizon-disaster-1409842182.
44. Goodman PS, Ramanujam R, Carroll JS, Edmondson AC, Hofmann DA, Sutcliffe KM (2011) Organizational errors: Directions for future research. Res. Organ. Behav. 31:151-176.
45. Greve HR (1998) Performance, aspirations and risky organizational change. Admin. Sci. Quart. 43(1):58-86.
46. Griliches Z (1990) Patent statistics as economic indicators: A survey. J. Econom. Literature 28(4):1661-1707.
47. Haunschild PR, Rhee M (2004) The role of volition in organizational learning: The case of automotive product recalls. Management Sci. 50(11):1545-1560.
48. Haunschild PR, Sullivan BN (2002) Learning from complexity: Effects of prior accidents and incidents on airlines' learning. Admin. Sci. Quart. 47(4):609-643.
49. Hausman J, Hall BH, Griliches Z (1984) Econometric models for count data with an application to the patents-R&D relationship. Econometrica 52(4):909-938.
50. Heimann L (2005) Repeated failures in the management of high risk technologies. Eur. Management J. 23(1):105-117.
51. Henderson R, Cockburn I (1994) Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management J. 15(S1):63-84.
52. Hoetker G (2007) The use of logit and probit models in strategic management research: Critical issues. Strategic Management J. 28(4):331-343.
53. Holland PW (1986) Statistics and causal inference (in theory and methods). J. Amer. Statist. Assoc. 81(396):945-960.
54. Kamp J (2010) Boston Scientific wants to spend on growth, not big studies. Dow Jones Newswires (December 1), http://www.advfn.com/nyse/StockNews.asp?stocknews=BSX&article=41075147.
55. Lampel J, Shamsie J, Shapira Z (2009) Experiencing the improbable: Rare events and organizational learning. Organ. Sci. 20(5): 835-845.
56. Lapré MA, Nembhard IM (2011) Inside the organizational learning curve: Understanding the organizational learning process. Foundations Trends Tech., Inform. Oper. Management 4(1):1-110.
57. Levinthal DA, March JG (1993) The myopia of learning. Strategic Management J. 14(8):95-112.
58. Levitt B, March JG (1988) Organizational learning. Annual Rev. Sociol. 14:319-340.
59. Lewis MW, Welsh MA, Dehler GE, Green SG (2002) Product development tensions: Exploring contrasting styles of project management. Acad. Management J. 45(3):546-564.
60. Macher JT, Boerner CS (2006) Experience and scale and scope economies: Trade-offs and performance in development. Strategic Management J. 27(9):845-865.
61. Madsen PM (2009) These lives will not be lost in vain: Organizational learning from disaster in U.S. coal mining. Organ. Sci. 20(5):861-875.
62. Madsen PM, Desai V (2010) Failing to learn? The effects of failure and success on organizational learning in the global orbital launch vehicle industry. Acad. Management J. 53(3):451-476.
63. Mahler JG, Hogan Casamayou M (2009) Organizational Learning at NASA: The Challenger and Columbia Accidents (Georgetown University Press, Washington, DC).
64. Maor M (2011) Organizational reputations and the observability of public warnings in 10 pharmaceutical markets. Governance 24(3):557-582.
65. March JG (1991) Exploration and exploitation in organizational learning. Organ. Sci. 2(1):71-87.
66. March JG, Sproull LS, Tamuz M (1991) Learning from samples of one or fewer. Organ. Sci. 2(1):1-13.
67. Martin de Holan P, Nelson P (2004) Remembrance of things past? The dynamics of organizational forgetting. Management Sci. 50(11):1603-1613.
68. Maybury-Lewis D, Almagor U (1989) The Attraction of Opposites: Thought and Society in the Dualistic Mode (University of Michigan Press, Ann Arbor).
69. McGrath RG (1997) A real options logic for initiating technology positioning investments. Acad. Management Rev. 22(4):974-996.
70. Miller D (1994) What happens after success: The perils of excellence. J. Management Stud. 31(3):325-358.
71. Miron E, Erez M, Naveh E (2004) Do personal characteristics and cultural values that promote innovation, quality, and efficiency compete or complement each other? J. Organ. Behav. 25(2): 175-199.
72. Morris MW, Moore PC (2000) The lessons we (don't) learn: Counterfactual thinking and organizational accountability after a close call. Admin. Sci. Quart. 45(4):737-765.
73. Naveh E, Erez M (2004) Innovation and attention to detail in the quality improvement paradigm. Management Sci. 50(11): 1576-1586.
74. Nelson RR (1991) Why do firms differ, and how does it matter? Strategic Management J. 12(S2):61-74.
75. Nickerson JA, Zenger TR (2002) Being efficiently fickle: A dynamic theory of organizational choice. Organ. Sci. 13(5):547-566.
76. Ocasio W (1997) Towards an attention-based view of the firm. Strategic Management J. 18(6):187-206.
77. O'Reilly CA III, Tushman ML (2013) Organizational ambidexterity: Past, present, and future. Acad. Management Perspect. 27(4):324-338.
78. Patel P, Pavitt K (1995) Patterns of technological activity: Their measurement and interpretation. Stoneman P, ed. Handbook of the Economics of Innovation and Technological Change (Blackwell, Oxford, UK), 14-51.
79. Perrow C (1984) Normal Accidents: Living with High-Risk Technologies (Basic Books, New York).
80. Perrow C (1994) Accidents in high-risk systems. Tech. Stud. 1(1): 1-20.
81. Pettigrew AM (1990) Longitudinal field research on change: Theory and practice. Organ. Sci. 1(3):267-292.
82. Pharma Letter (2000) FDA says SB's Factive is non-approvable. (December 18), http://www.thepharmaletter.com/article/fda-says-sb-s-factive-is-non-approvable.
83. Pharma Letter (2002) Sepracor slumps as U.S. FDA turns down antihistamine product Soltara. (March 18), http://www.thepharmaletter.com/article/sepracor-slumps-as-us-fda-turns-down-antihistamine-product-soltara.
84. Polidoro F Jr (2013) The competitive implications of certifications: The effects of scientific and regulatory certifications on entries into new technical fields. Acad. Management J. 56(2):597-627.
85. Polidoro F Jr, Theeke M (2011) Getting competition down to a science: The effects of technological competition on firms' scientific publications. Organ. Sci. 23(4):1135-1153.
86. Polidoro F Jr, Toh PK (2011) Letting rivals come close or warding them off? The effects of substitution threat on imitation deterrence. Acad. Management J. 54(2):369-392.
87. Rerup C (2009) Attentional triangulation: Learning from unexpected rare crises. Organ. Sci. 20(5):876-893.
88. Rhee M, Valdez ME (2009) Contextual factors surrounding reputation damage with potential implications for reputation repair. Acad. Management Rev. 34(1):146-168.
89. Sharma A, Lacey N (2004) Linking product development outcomes to market valuation of the firm: The case of the U.S. pharmaceutical industry. J. Product Innovation Management 21(5):297-308.
90. Thomke S, Kuemmerle W (2002) Asset accumulation, interdependence and technological change: Evidence from pharmaceutical drug discovery. Strategic Management J. 23(7):619-635.
91. Tushman ML, Anderson P (1986) Technological discontinuities and organizational environments. Admin. Sci. Quart. 31(3):439-465.
92. Tushman ML, Romanelli E (1985) Organizational evolution: A metamorphosis model of convergence and reorientation. Res. Organ. Behav. 7:171-222.
93. Twedt S (1993) Deadly hospital mistakes are doomed to be repeated. Pittsburgh Post-Gazette (October 24) A1.
94. U.S. Congress, House Committee on Science (1986) Report of the presidential commission on the space shuttle Challenger accident. Report 99-106, U.S. House of Representatives, Washington, DC.
95. U.S. Congress, House Committee on Science (2003) NASA's organizational and management challenges in the wake of the Columbia disaster: Hearing before the Committee on Science. 108th Cong., 1st sess., October 23, 2003.
96. Vaughan D (1997) The Challenger Launch Decision: Risky Technology, Culture, and Deviance at NASA (University of Chicago Press, Chicago).
97. Vaughan D (2005) System effects: On slippery slopes, repeating negative patterns, and learning from mistake? Starbuck WH, Farjoun M, eds. Organization at the Limit: Lessons from the Columbia Disaster (Wiley-Blackwell, Oxford, UK), 41-59.
98. Walsh JP, Ungson GR (1991) Organizational memory. Acad. Management Rev. 16(1):57-91.
99. Weick KE (1987) Organizational culture as a source of high reliability. Calif. Management Rev. 29(2):112-127.
100. Weick KE, Sutcliffe KM, Obstfeld D (1999) Organizing for high reliability: Processes of collective mindfulness. Staw BM, Sutton FR, eds. Research in Organizational Behavior, Vol. 21 (JAI Press, Greenwich, CT), 81-123.
101. Woods DD (2005) Creating foresight: Lessons for enhancing resilience from Columbia. Starbuck WH, Farjoun M, eds. Organization at the Limit: Lessons from the Columbia Disaster (Wiley-Blackwell, Oxford, UK), 289-308.
102. Wooldridge JM (2002) Econometric Analysis of Cross Section and Panel Data (MIT Press, Cambridge, MA).